Applied Nutrition (APN) Trading Update summary

Financial performance

• H1 FY25 revenue reached £47.6 million, surpassing IPO guidance of £46 million and supporting full-year guidance of £100 million.

• Adjusted EBITDA margin and cash conversion remained robust and in line with market expectations.

• Manufacturing extension completed, increasing capacity to support revenue growth up to £160 million.

Strategic and operational progress

• New product launches included Coleen Rooney wellness supplements, Sparkling Protein Water, Creaflow, Blackstak, and Creatine Gummies.

• Expanded distribution with new listings in Holland & Barrett, Canada, South America, Singapore, and the US.

• Collaboration with Vimto for the Endurance range and Chiquita for the US market.

Marketing and brand development

• Signed Daniel Dubois as brand ambassador and aired first TV advert for the Coleen range.

• Participated in five expos in the Middle East and UK, with more planned in UAE, Columbia, and USA.

• IPO in October 2024 enhanced brand profile and industry recognition.